Biopsychosocial predictors of fatigue in chronic hepatitis C

Robin C Hilsabeck1, Tarek I Hassanein, William Perry

  • 1Department of Neuropsychiatry and Behavioral Science, Texas Tech University Health Sciences Center, 3601 4th Street, STOP 8321, Lubbock, TX 79430, USA. robin.hilsabeck@ttuhsc.edu

Insights

Biopsychosocial factors significantly impact fatigue in patients with chronic hepatitis C (CHC). Improving social and physical functioning, alongside reducing depression, is key for managing fatigue in CHC patients.

Area of Science:

  • Hepatology
  • Psychology
  • Public Health

Background:

  • Chronic hepatitis C (CHC) is a significant global health concern.
  • Fatigue is a prevalent and debilitating symptom in CHC patients.
  • Understanding the biopsychosocial determinants of fatigue is crucial for effective management.

Purpose of the Study:

  • To explore the association between biopsychosocial variables and fatigue severity in CHC patients.
  • To identify potential targets for interventions aimed at alleviating fatigue.

Main Methods:

  • A cohort of 94 CHC patients not receiving antiviral therapy was assessed.
  • Data collected included demographics, fatigue, quality of life, and depression.
  • Fibrosis stage and medical data were retrieved from patient records.

Main Results:

  • Poor social functioning emerged as the strongest predictor of fatigue.
  • Poor physical functioning and increased depression were also significant predictors.
  • Female gender was identified as another contributing factor to fatigue.

Conclusions:

  • Treatment strategies for CHC-related fatigue should prioritize enhancing social and physical functioning.
  • Reducing depressive symptoms is essential for managing fatigue.
  • Further research into interventions like support groups and counseling for social functioning is recommended.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Fatigue01:21

Fatigue

Fatigue occurs when materials rupture under repeated or fluctuating loads, even at stress levels far below their static breaking strength. It typically results in brittle failure, even for ductile materials. It is a critical consideration in designing machines and structural components subjected to repetitive or varying loads. The nature of these loadings can range from fluctuating loads like unbalanced pump impellers causing vibrations to repeatedly bending a thin steel rod wire back and forth...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Muscle Recovery and Fatigue01:24

Muscle Recovery and Fatigue

Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective response...